Neftaly Health and Wellness Services

NeftalyApp COURSES Partner INVEST Corporate CHARITY Divisions

[Contact SayPro] [About SayPro][Services] [Recruit] [Agri] [Apply] [Login] [Courses] [Corporate Training] [Study] [School] [Sell Courses] [Career Guidance] [Training Material] [ListBusiness/NPO/Govt] [Shop] [Volunteer] [Internships] [Jobs] [Tenders] [Funding] [Learnerships] [Bursary] [Freelancers] [Sell] [Camps] [Events&Catering] [Research] [Laboratory] [Sponsor] [Machines] [Partner] [Advertise]  [Influencers] [Publish] [Write ] [Invest] [Franchise] [Staff] [CharityNPO] [Donate] [Give] [Clinic/Hospital] [Competitions] [Travel] [Idea/Support] [Events] [Classified] [Groups] [Pages]

Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

Tag: Hepatitis

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

Written by

Mapaseka Matabane

in

  • Neftaly Hepatitis B Vaccination and Screening

    Neftaly Hepatitis B Vaccination and Screening

    Neftaly’s Related Activities

    • Vaccination Support for Targeted Groups
      Neftaly coordinated Hepatitis A and B vaccinations for specific community initiatives—e.g., providing injections to wastewater treatment plant staff in a municipal partnership southernafricayouth.org.
    • Broader Community & Health Promotion Work
      Neftaly runs youth health programs that include screening, health awareness, and referrals—though there is no publicly documented, structured Hepatitis B-specific campaign saypro.onlinesouthernafricayouth.org.

    ???? Context: Hepatitis B in South Africa

    • The Expanded Programme on Immunisation (EPI) has included Hepatitis B vaccination since 1995, administered at 6, 10, and 14 weeks of age in infants—but there is still no universal birth dose included in the national schedule PMCPubMed+1.
    • Seroprotection (antibody) rates among adolescents remain low (as little as ~32% in ages 15–17), indicating a gap in protection as immunity wanes over time PMC.

    ???? How Neftaly Could Be Involved in Hepatitis B Vaccination & Screening

    While Neftaly doesn’t advertise a formal Hepatitis B program, its existing capabilities suggest that it could support:

    • Organising vaccination drives for high-risk groups or settings (similar to the injection initiative with municipal workers).
    • Community education campaigns to raise awareness about screening and preventive care.
    • Screening events or referrals for HBsAg and anti-HBs testing.

    ???? Hepatitis B Testing & Vaccination in South Africa

    • Testing (screening): Includes HBsAg (antigen) and anti-HBs (antibody) assessments. This helps determine infection or immunity status. Some healthcare environments require testing before internships or certain jobs Reddit.
    • Vaccination protocol: For those unvaccinated, the standard adult schedule involves three doses over six months. Healthcare workers are advised to complete the full series and ideally have antibody titres checked afterward (~10 IU/L or higher indicates protection) safpj.co.zaReddit.

    ???? Summary Table

    TopicKey Points
    Official Neftaly programNo dedicated HepB immunisation/screening initiative found
    Existing related activityLimited vaccine delivery for targeted groups; health promotion and education programs
    South African contextInfant schedule includes 6/10/14 weeks doses; no birth dose; low adolescent seroprotection
    Potential Neftaly roleVaccination drives, screenings, awareness campaigns, risk‑group targeting

    ✅ Next Steps

    Would you like help with any of the following?

    • Searching for Hepatitis B screening clinics or vaccination providers in Pretoria or broader Gauteng.
    • Understanding the testing and vaccination process in your region (e.g., where to go, costs, eligibility).
    • Exploring how Neftaly or similar organizations might help implement a community hepatitis B campaign.

    Just let me know what you’re interested in!

    Sources

    To access more intelligence, create an account or log in.

  • Neftaly Autoimmune Hepatitis Screening

    Neftaly Autoimmune Hepatitis Screening

  • Neftaly Hepatitis C Screening and Management

    Neftaly Hepatitis C Screening and Management

  • Neftaly Hepatitis Screening and Vaccination Programs

    Neftaly Hepatitis Screening and Vaccination Programs

    Neftaly Hepatitis Screening and Vaccination Programs

    Protecting Communities Through Prevention, Early Detection, and Education

    Hepatitis is a serious public health concern that affects millions of people worldwide. At Neftaly, we are committed to reducing the burden of hepatitis through comprehensive screening and vaccination programs designed to detect infections early, prevent transmission, and promote long-term health.

    Understanding Hepatitis

    Hepatitis refers to inflammation of the liver, commonly caused by viral infections such as:

    • Hepatitis A (HAV): Usually spread through contaminated food or water
    • Hepatitis B (HBV): Transmitted through blood, sexual contact, or from mother to child at birth
    • Hepatitis C (HCV): Primarily spread through blood-to-blood contact, often via unsterile medical equipment or needle sharing

    Many individuals with hepatitis may not show symptoms until significant liver damage has occurred—making early screening and vaccination critical.

    Neftaly’s Comprehensive Program Includes:

    ✔ Community-Based Screening

    • Rapid, confidential testing for Hepatitis B and C
    • On-site screenings at clinics, schools, workplaces, and community events
    • Linkage to care and follow-up for those who test positive

    ✔ Vaccination Services

    • Hepatitis A and B vaccinations for children, adolescents, and high-risk adults
    • Mobile and in-clinic vaccination campaigns
    • Vaccination drives in partnership with local healthcare providers and public health departments

    ✔ Education and Awareness

    • Public education campaigns to raise awareness of hepatitis risks and prevention
    • Training for healthcare workers, educators, and community leaders
    • Multilingual materials and culturally appropriate resources

    ✔ Data and Reporting

    • Monitoring and evaluation to measure program impact
    • Reporting to public health authorities to support national hepatitis elimination goals

    Who Should Be Screened or Vaccinated?

    Neftaly prioritizes screening and vaccination for:

    • Infants and young children (per national immunization schedules)
    • Pregnant women
    • Healthcare workers and caregivers
    • Individuals with multiple sexual partners or a history of STIs
    • People who inject drugs
    • Individuals with HIV or other chronic conditions
    • Communities with high hepatitis prevalence or limited access to healthcare

    Why Choose Neftaly?

    • ✅ Accessible and Mobile Services: Bringing care directly to the communities that need it most
    • ✅ Expert-Led Programs: Run by trained healthcare professionals and supported by the latest medical guidelines
    • ✅ Integrated Care Pathways: From screening to diagnosis, vaccination, and treatment referrals
    • ✅ Community Partnership Model: Working hand-in-hand with local leaders and organizations for greater impact

    Get Involved or Schedule a Program

    Neftaly’s Hepatitis Screening and Vaccination Programs are open to healthcare partners, schools, employers, NGOs, and government agencies.

  • Neftaly Hepatitis B and C Diagnosis

    Neftaly Hepatitis B and C Diagnosis

    Neftaly: Hepatitis B and C Diagnosis

    Overview

    Hepatitis B (HBV) and Hepatitis C (HCV) are viral infections that primarily affect the liver. Early diagnosis is crucial to prevent chronic liver disease, cirrhosis, hepatocellular carcinoma, and to reduce transmission risk. Healthcare professionals must be equipped with knowledge of risk factors, screening strategies, and interpretation of diagnostic tests.

    1. Risk Factors

    Hepatitis B:

    • Unprotected sexual contact with an infected individual
    • Perinatal transmission from mother to child
    • Exposure to contaminated needles or medical instruments
    • Household contact with infected persons

    Hepatitis C:

    • History of intravenous drug use
    • Blood transfusions or organ transplants before 1992
    • Hemodialysis patients
    • Healthcare workers with occupational exposure
    • Unsterilized tattooing or body piercing

    2. Clinical Presentation

    Both HBV and HCV may be asymptomatic initially. When present, symptoms include:

    • Fatigue and malaise
    • Jaundice (yellowing of skin and eyes)
    • Dark urine and pale stools
    • Abdominal discomfort (right upper quadrant)
    • Nausea, vomiting, and loss of appetite

    Chronic infections often remain silent until significant liver damage occurs.

    3. Diagnostic Approach

    A. Laboratory Testing

    Hepatitis B:

    1. Serologic Markers:
      • HBsAg (Hepatitis B surface antigen): Indicates active infection
      • Anti-HBs (Hepatitis B surface antibody): Indicates immunity
      • Anti-HBc (Hepatitis B core antibody): Indicates past or ongoing infection
      • HBeAg and Anti-HBe: Assess viral replication and infectivity
    2. Liver Function Tests (LFTs):
      • Elevated ALT and AST suggest liver inflammation
    3. HBV DNA (PCR):
      • Quantifies viral load, important for treatment decisions

    Hepatitis C:

    1. HCV Antibody (Anti-HCV):
      • Initial screening test; indicates exposure
    2. HCV RNA (PCR):
      • Confirms active infection
      • Quantifies viral load
    3. Genotyping:
      • Determines HCV genotype to guide antiviral therapy

    B. Imaging and Liver Assessment

    • Ultrasound: To assess liver size, fibrosis, or cirrhosis
    • FibroScan / Elastography: Non-invasive assessment of liver fibrosis
    • Liver biopsy: Rarely used, reserved for complex cases

    4. Screening Recommendations

    • High-risk groups should be screened regularly (e.g., healthcare workers, people living with HIV, individuals with multiple sexual partners, intravenous drug users).
    • Pregnant women: Screen for HBV to prevent perinatal transmission.
    • Blood donors: Mandatory screening for HBV and HCV.

    5. Counseling and Follow-Up

    • Discuss transmission prevention strategies (safe sex, safe injections, vaccination for HBV).
    • Explain the importance of adherence to follow-up appointments for monitoring liver function and viral load.
    • Provide emotional support, especially for newly diagnosed patients.

    6. Key Points for Healthcare Professionals

    • Early detection is critical for preventing chronic liver disease.
    • Understand the difference between HBV and HCV serology for accurate interpretation.
    • Tailor screening and monitoring based on patient risk factors and comorbidities.
    • Link patients promptly to antiviral therapy when indicated.

    This content can also be formatted into training modules with diagrams showing the HBV and HCV lifecycle, flowcharts for diagnostic pathways, and checklists for risk assessment.

  • Neftaly Hepatitis Screening in High-Risk Groups

    Neftaly Hepatitis Screening in High-Risk Groups

    Neftaly Hepatitis Screening in High-Risk Groups

    Early Detection Saves Lives

    Hepatitis is a serious liver infection caused by viruses such as hepatitis A, B, and C. Many people with hepatitis may not experience symptoms initially, making early screening essential—especially for those at higher risk.

    At Neftaly, we prioritize proactive hepatitis screening to identify infections early, provide timely treatment, and reduce the risk of liver damage and transmission to others.

    Who Should Get Screened?

    Certain individuals have a higher risk of hepatitis infection and should undergo routine screening:

    • People born between 1945 and 1965 (baby boomers)
    • Individuals with a history of intravenous drug use or sharing needles
    • Those with multiple sexual partners or a history of sexually transmitted infections
    • People who received blood transfusions or organ transplants before 1992
    • Healthcare workers or others exposed to blood and bodily fluids
    • Individuals living with HIV or other immunocompromising conditions
    • Babies born to mothers infected with hepatitis B or C
    • People from regions with high hepatitis prevalence (e.g., Asia, Africa)
    • Anyone with unexplained liver disease or abnormal liver function tests

    Neftaly Screening Services

    Our hepatitis screening includes:

    1. Comprehensive Risk Assessment

    We start by understanding your personal and medical history to tailor screening recommendations.

    2. Blood Testing

    Tests detect hepatitis A, B, and C infections, identify immunity status, and determine the need for vaccination or treatment.

    3. Vaccination and Prevention

    For those at risk of hepatitis A or B, Neftaly offers vaccinations to protect your health.

    4. Follow-Up and Treatment Referrals

    If screening indicates infection, our team coordinates prompt referrals to specialists for antiviral therapy and ongoing liver care.

    Why Choose Neftaly for Hepatitis Screening?

    • Confidential and compassionate care
    • Fast and accurate testing
    • Personalized counseling on prevention and treatment
    • Integrated follow-up to manage your health

    Take Charge of Your Liver Health

    If you belong to a high-risk group or want to learn more about hepatitis screening, contact Neftaly today. Early detection is key to protecting your liver and overall health.

  • Neftaly Hepatitis C Screening and Management

    Neftaly Hepatitis C Screening and Management

    Neftaly Hepatitis C Screening and Management

    Overview

    Hepatitis C is a serious viral infection that affects the liver, often progressing silently over years without symptoms. If left untreated, it can lead to liver damage, cirrhosis, liver cancer, or even death. However, with early detection and effective treatment, Hepatitis C can be cured.

    At Neftaly, we are committed to supporting individuals and communities with accessible, reliable, and confidential Hepatitis C screening and management services.

    Why Hepatitis C Screening Matters

    • Early Detection Saves Lives
      Most people with Hepatitis C do not know they are infected. Early screening can prevent long-term health complications.
    • It’s Highly Treatable
      Modern antiviral treatments can cure more than 95% of Hepatitis C infections with minimal side effects.
    • Protect Yourself and Others
      Early diagnosis reduces the risk of transmission to others and allows you to take control of your health.

    Who Should Get Screened?

    According to global health guidelines, you should consider screening if you:

    • Are between the ages of 18 and 79
    • Have ever injected or shared drug equipment
    • Received a blood transfusion or organ transplant before 1992
    • Were born in a country with high Hepatitis C prevalence
    • Are living with HIV
    • Have abnormal liver function tests
    • Are in a high-risk occupational setting (e.g., healthcare workers)

    Our Services

    1. Confidential Screening

    Neftaly offers fast and confidential screening using reliable, WHO-approved rapid testing kits or laboratory-based blood tests. Results are delivered with sensitivity and clarity.

    2. Medical Evaluation and Diagnosis

    If your test is positive, our healthcare professionals will guide you through further diagnostic testing, including viral load and liver function assessments.

    3. Individualized Treatment Plans

    We work with certified medical practitioners to develop a personalized treatment plan that fits your health needs, lifestyle, and preferences—whether through direct-acting antivirals (DAAs) or supportive care.

    4. Ongoing Support and Monitoring

    Neftaly provides continued monitoring throughout your treatment journey, including follow-up testing to ensure viral clearance and post-treatment health evaluations.

    5. Community Outreach and Education

    We’re dedicated to raising awareness, reducing stigma, and empowering communities through educational workshops and health promotion campaigns.

    Why Choose Neftaly?

    • Expertise You Can Trust: Our team of trained healthcare professionals brings years of experience in infectious disease management.
    • Client-Centered Approach: Compassion, respect, and confidentiality are at the core of everything we do.
    • Affordable Access: We aim to make Hepatitis C screening and treatment accessible for all, regardless of background or ability to pay.
    • Community Impact: Neftaly partners with local organizations to reach underserved populations and promote healthier communities.

    Get Tested. Get Treated. Get Cured.

    Take the first step toward a healthier future. Contact Neftaly today to schedule your Hepatitis C screening or to learn more about our management programs.

  • Neftaly POCT for hepatitis C screening and treatment

    Neftaly POCT for hepatitis C screening and treatment

  • Neftaly Hepatitis Services

    Neftaly Hepatitis Services

  • Neftaly The relationship between water quality and hepatitis A outbreaks

    Neftaly The relationship between water quality and hepatitis A outbreaks